Pain management, fluid therapy and thromboprophylaxis after pancreatoduodenectomy: a worldwide survey among surgeons.

Details

Serval ID
serval:BIB_4C68B480FFAF
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Pain management, fluid therapy and thromboprophylaxis after pancreatoduodenectomy: a worldwide survey among surgeons.
Journal
HPB
Author(s)
Groen J.V., Henrar R.B., Hanna Sawires R.G., AlEassa E., Martini C.H., Bonsing B.A., Vahrmeijer A.L., Besselink M.G., Pecorelli N., Hackert T., Ishizawa T., Miller T., Mungroop T.H., Samra J., Sauvanet A., Adham M., Demartines N., Christophi C., Morris-Stiff G., Mieog JSD
ISSN
1477-2574 (Electronic)
ISSN-L
1365-182X
Publication state
Published
Issued date
04/2022
Peer-reviewed
Oui
Volume
24
Number
4
Pages
558-567
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
The aim of this survey was to assess practices regarding pain management, fluid therapy and thromboprophylaxis in patients undergoing pancreatoduodenectomy on a global basis.
This survey study among surgeons from eight (inter)national scientific societies was performed according to the CHERRIES guideline.
Overall, 236 surgeons completed the survey. ERAS protocols are used by 61% of surgeons and respectively 82%, 93%, 57% believed there is a relationship between pain management, fluid therapy, and thromboprophylaxis and clinical outcomes. Epidural analgesia (50%) was most popular followed by intravenous morphine (24%). A restrictive fluid therapy was used by 58% of surgeons. Chemical thromboprophylaxis was used by 88% of surgeons. Variations were observed between continents, most interesting being the choice for analgesic technique (transversus abdominis plane block was popular in North America), restrictive fluid therapy (little use in Asia and Oceania) and duration of chemical thromboprophylaxis (large variation).
The results of this international survey showed that only 61% of surgeons practice ERAS protocols. Although the majority of surgeons presume a relationship between pain management, fluid therapy and thromboprophylaxis and clinical outcomes, variations in practices were observed. Additional studies are needed to further optimize, standardize and implement ERAS protocols after pancreatic surgery.
Keywords
Analgesics, Opioid/therapeutic use, Anticoagulants/adverse effects, Fluid Therapy/adverse effects, Humans, Pain Management/methods, Pain, Postoperative/prevention & control, Pancreaticoduodenectomy/adverse effects, Surgeons, Venous Thromboembolism/prevention & control
Pubmed
Open Access
Yes
Create date
19/10/2021 13:27
Last modification date
27/04/2022 6:37
Usage data